Dr Reddy’s launches Zoledronic Acid Injection

05 Mar 2013 Evaluate

Dr Reddy's Laboratories, has launched Zoledronic Acid Injection (4mg/5ml), a bioequivalent generic version of Zometa (zoledronic acid) 4 mg/5ml injection in the US market on March 4, 2012, following the approval by the United States Food & Drug Administration (USFDA) of the company's ANDA for Zoledronic acid injection (4 mg/5ml). The company’s Zoledronic Acid Injection 4mg/5ml is available in a single use vial of concentrate.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1235.15 18.00 (1.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×